These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 12472362)

  • 1. Mycophenolate mofetil for the treatment of cutaneous lupus erythematosus with smoldering systemic involvement.
    Hanjani NM; Nousari CH
    Arch Dermatol; 2002 Dec; 138(12):1616-8. PubMed ID: 12472362
    [No Abstract]   [Full Text] [Related]  

  • 2. Bullous systemic lupus erythematosus: response to dapsone in two patients.
    Sirka CS; Padhi T; Mohanty P; Patel DK; Parida PR; Kar CR
    Indian J Dermatol Venereol Leprol; 2005; 71(1):54-6. PubMed ID: 16394370
    [No Abstract]   [Full Text] [Related]  

  • 3. Mycophenolate sodium for subacute cutaneous lupus erythematosus resistant to standard therapy.
    Kreuter A; Tomi NS; Weiner SM; Huger M; Altmeyer P; Gambichler T
    Br J Dermatol; 2007 Jun; 156(6):1321-7. PubMed ID: 17408395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycophenolate mofetil and hydroxychloroquine: an effective treatment for recalcitrant cutaneous lupus erythematosus.
    Sadlier M; Kirby B; Lally A
    J Am Acad Dermatol; 2012 Jan; 66(1):160-1; author reply 161-2. PubMed ID: 22177639
    [No Abstract]   [Full Text] [Related]  

  • 5. The quinacrine experience in a population of patients with cutaneous lupus erythematosus and dermatomyositis.
    Mittal L; Werth VP
    J Am Acad Dermatol; 2017 Aug; 77(2):374-377. PubMed ID: 28711090
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of tacrolimus 0.1% ointment in cutaneous lupus erythematosus: a multicenter, randomized, double-blind, vehicle-controlled trial.
    Kuhn A; Gensch K; Haust M; Schneider SW; Bonsmann G; Gaebelein-Wissing N; Lehmann P; Wons A; Reitmeir P; Ruland V; Luger TA; Ruzicka T
    J Am Acad Dermatol; 2011 Jul; 65(1):54-64, 64.e1-2. PubMed ID: 21501887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus.
    Buratti S; Szer IS; Spencer CH; Bartosh S; Reiff A
    J Rheumatol; 2001 Sep; 28(9):2103-8. PubMed ID: 11550982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of increasing the dose of hydroxychloroquine (HCQ) in patients with refractory cutaneous lupus erythematosus (CLE): An open-label prospective pilot study.
    Chasset F; Arnaud L; Costedoat-Chalumeau N; Zahr N; Bessis D; Francès C
    J Am Acad Dermatol; 2016 Apr; 74(4):693-9.e3. PubMed ID: 26850655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of mycophenolate mofetil in antimalarial-resistant cutaneous lupus erythematosus.
    Gammon B; Hansen C; Costner MI
    J Am Acad Dermatol; 2011 Oct; 65(4):717-721.e2. PubMed ID: 21641078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent erythema multiforme/Stevens-Johnson syndrome: response to mycophenolate mofetil.
    Davis MD; Rogers RS; Pittelkow MR
    Arch Dermatol; 2002 Dec; 138(12):1547-50. PubMed ID: 12472339
    [No Abstract]   [Full Text] [Related]  

  • 11. Mycophenolic acid exposure and complement fraction C3 influence inosine 5'-monophosphate dehydrogenase activity in systemic lupus erythematosus.
    Mino Y; Naito T; Shimoyama K; Ogawa N; Kawakami J
    Ann Clin Biochem; 2017 Jul; 54(4):490-494. PubMed ID: 27538768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin manifestations of systemic lupus erythematosus refractory to multiple treatment modalities: poor results with mycophenolate mofetil.
    Pisoni CN; Obermoser G; Cuadrado MJ; Sanchez FJ; Karim Y; Sepp NT; Khamashta MA; Hughes GR
    Clin Exp Rheumatol; 2005; 23(3):393-6. PubMed ID: 15971430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orofacial granulomatosis successfully treated with mycophenolate mofetil.
    Antonyan AS; Pena-Robichaux V; McHargue CA
    J Am Acad Dermatol; 2014 Jun; 70(6):e137-9. PubMed ID: 24831337
    [No Abstract]   [Full Text] [Related]  

  • 14. Differential effects of cyclophosphamide and mycophenolate mofetil on cellular and serological parameters in patients with systemic lupus erythematosus.
    Fassbinder T; Saunders U; Mickholz E; Jung E; Becker H; Schlüter B; Jacobi AM
    Arthritis Res Ther; 2015 Apr; 17(1):92. PubMed ID: 25890338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of thromboembolic events in patients treated with thalidomide for cutaneous lupus erythematosus: A multicenter retrospective study.
    Cesbron E; Bessis D; Jachiet M; Lipsker D; Cordel N; Bouaziz JD; Bagot M; Arnaud L; Barbaud A; Francès C; Chasset F;
    J Am Acad Dermatol; 2018 Jul; 79(1):162-165. PubMed ID: 29496481
    [No Abstract]   [Full Text] [Related]  

  • 16. Lenalidomide in treatment-refractory cutaneous lupus erythematosus: Efficacy and safety in a 52-week trial.
    Okon L; Rosenbach M; Krathen M; Rose M; Propert K; Okawa J; Werth V
    J Am Acad Dermatol; 2014 Mar; 70(3):583-4. PubMed ID: 24528907
    [No Abstract]   [Full Text] [Related]  

  • 17. Lenalidomide treatment of cutaneous lupus erythematosus: the Mayo Clinic experience.
    Kindle SA; Wetter DA; Davis MD; Pittelkow MR; Sciallis GF
    Int J Dermatol; 2016 Aug; 55(8):e431-9. PubMed ID: 26873674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of subacute cutaneous lupus erythematosus with mycophenolate mofetil.
    Schanz S; Ulmer A; Rassner G; Fierlbeck G
    Br J Dermatol; 2002 Jul; 147(1):174-8. PubMed ID: 12100205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of topical tacrolimus in the treatment of various cutaneous manifestations of lupus erythematosus.
    von Pelchrzim R; Schmook T; Friedrich M; Worm M
    Int J Dermatol; 2006 Jan; 45(1):84-5. PubMed ID: 16426386
    [No Abstract]   [Full Text] [Related]  

  • 20. Chilblain lupus erythematosus treated successfully with mycophenolate mofetil.
    Gouillon L; Debarbieux S; Berruyer M; Fabien N; Lega JC; Thomas L
    Int J Dermatol; 2017 Aug; 56(8):e158-e159. PubMed ID: 28345755
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.